Sign in
4

Changes in Ownership

Acrivon Therapeutics, Inc. Filed Acc 0000905148-26-004065

Chief Business Officer acquired 30,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Levin Michaela · Chief Business Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2026-08-31 Grant or award : show line 1 in the form +30,000 30,000 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-08-31 Grant or award : show line 2 in the form Stock Option (Right to Buy) +130,000 130,000 D
Loading xslF345X06/form4.xml…